Since 18 of December 2019 conferences.iaea.org uses Nucleus credentials. Visit our help pages for information on how to Register and Sign-in using Nucleus.

Assessment of Radiation Levels of 99Mo/99mTc Generator Packages during transport

Not scheduled
20m
Vienna

Vienna

POSTER Track 3 Safety and Security during Transport Operations

Speaker

Abdelbagi Osman (Department of Nuclear medicine, National Cancer Institute, University of Gezira, Wad Medani, Sudan)

Description

Abdelbagi O. Osman¹, Suleiman Zubaloy1, Suliman Salih2,3
¹ National Cancer Institute, University of Gezira, Wad Medani, Sudan
2 Department of Radiography & Medical Imaging, Fatima College of Health Sciences, Al Maqam, Al Ain, UAE
3Wad Medani University, Wad Medani, Gezira State, Sudan
Abstract: 99Mo/99mTc generators are widely used in nuclear medicine to produce technetium-99m for diagnostic imaging. Ensuring safe handling and transport of these generators is essential for protecting workers, the public, and the environment. This study aimed to measure radiation levels for Monorol 99Mo/99mTc generator packages upon receipt at a nuclear medicine department to verify compliance with international safety standards (IAEA, 2018).
Forty-four generator packages were assessed during 2016–2018. Dose rate measurements were taken using a calibrated survey meter (RADOS RDS-200, calibration factor 0.94) at four positions: direct top surface, one meter above top surface, direct outer surface, and one meter from outer surface. Results were analyzed separately for 30 GBq and 15 GBq generators, and compared with reference studies (Ahasan, 2004) and regulatory thresholds (IAEA, 1999).
All measured values were below IAEA transport limits of 2mSv/hr at package surface and 0.1mSv/hr at one meter (IAEA, 2018).
This study concluded that all generator packages met IAEA and ALARA safety requirements, demonstrating effective shielding and transport practices.
Keywords: 99Mo/99mTc-generators packages, radiation survey meters, and radiation workers

Author

Abdelbagi Osman (Department of Nuclear medicine, National Cancer Institute, University of Gezira, Wad Medani, Sudan)

Co-author

Dr Sulieman Mohamed Zobali (University of Gezira)

Presentation materials